Carolinas Wealth Consulting LLC Guardant Health, Inc. Transaction History

Carolinas Wealth Consulting LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $962 - $1,417	-42 Reduced 29.17%	102 $2,000
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $6,287 - $8,784	144 New	144 $8,000
Q2 2022 Aug 16, 2022	SELL	$28.82 - $77.35 $3,804 - $10,210	-132 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$48.25 - $100.49 $2,702 - $5,627	-56 Reduced 29.79%	132 $9,000
Q2 2021 Aug 17, 2021	BUY	$109.77 - $165.68 $1,975 - $2,982	18 Added 10.59%	188 $23,000
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $11,395 - $15,496	114 Added 203.57%	170 $22,000
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $4,497 - $6,260	56 New	56 $6,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.